Aspiriant LLC Sells 1,111 Shares of VanEck Vectors Biotech ETF (NASDAQ:BBH)

Aspiriant LLC decreased its stake in VanEck Vectors Biotech ETF (NASDAQ:BBH) by 14.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,649 shares of the company’s stock after selling 1,111 shares during the period. Aspiriant LLC owned about 0.25% of VanEck Vectors Biotech ETF worth $785,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the company. Royal Bank of Canada grew its holdings in shares of VanEck Vectors Biotech ETF by 28.4% during the 2nd quarter. Royal Bank of Canada now owns 41,427 shares of the company’s stock valued at $5,343,000 after purchasing an additional 9,175 shares during the last quarter. Bank of America Corp DE grew its holdings in shares of VanEck Vectors Biotech ETF by 27.2% during the 2nd quarter. Bank of America Corp DE now owns 37,599 shares of the company’s stock valued at $4,849,000 after purchasing an additional 8,049 shares during the last quarter. Mogy Joel R Investment Counsel Inc. grew its holdings in shares of VanEck Vectors Biotech ETF by 5.5% during the 3rd quarter. Mogy Joel R Investment Counsel Inc. now owns 23,999 shares of the company’s stock valued at $2,831,000 after purchasing an additional 1,245 shares during the last quarter. Pacific Sun Financial Corp bought a new position in shares of VanEck Vectors Biotech ETF during the 2nd quarter valued at $809,000. Finally, Janney Montgomery Scott LLC grew its holdings in shares of VanEck Vectors Biotech ETF by 1.7% during the 3rd quarter. Janney Montgomery Scott LLC now owns 6,095 shares of the company’s stock valued at $719,000 after purchasing an additional 100 shares during the last quarter. 20.19% of the stock is currently owned by hedge funds and other institutional investors.

BBH stock opened at $131.51 on Friday. VanEck Vectors Biotech ETF has a 52 week low of $103.25 and a 52 week high of $132.80. The firm’s fifty day moving average is $122.10 and its 200 day moving average is $123.16.

Featured Article: Cost of equity and a company’s balance sheet

Institutional Ownership by Quarter for VanEck Vectors Biotech ETF (NASDAQ:BBH)

Receive News & Ratings for VanEck Vectors Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Vectors Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.